Condition: Non-metastatic Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
This is a non-inferiority, multicenter, randomized phase 3 trial aimed at investigating the impact of individualized primary clinical target volume based on margin expansion on patients' prognosis and complications compared with the consensus primary clinical target volume based on margin expansion and stepwise extension pattern for patients with newly diagnosed non-metastatic nasopharyngeal carcinoma.
This description comes directly from the study's public registry record.
Jun Ma, Prof. · +86-20-87343469 · majun2@mail.sysu.edu.cn
Kai-Bin Yang, Dr. · +86-13725368062 · yangkb@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Dongguan People's Hospital | Dongguan, Guangdong, China | Not Yet Recruiting |
| Sun Yat-Sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Xiangya Hospital Central South University | Changsha, Hunan, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07661771